According to Aurinia Pharmaceuticals
's latest financial reports the company has $0.35 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.35 B | -9.99% |
2022-12-31 | $0.38 B | -16.45% |
2021-12-31 | $0.46 B | 17.01% |
2020-12-31 | $0.39 B | 30.16% |
2019-12-31 | $0.30 B | 143.15% |
2018-12-31 | $0.12 B | -27.44% |
2017-12-31 | $0.17 B | 337.49% |
2016-12-31 | $39.64 M | 151.69% |
2015-12-31 | $15.75 M | -51.83% |
2014-12-31 | $32.7 M | 1695.94% |
2013-12-31 | $1.82 M | 884.32% |
2012-12-31 | $0.18 M | -96.88% |
2011-12-31 | $5.92 M | -6.69% |
2010-12-31 | $6.34 M | 38.51% |
2009-12-31 | $4.58 M | -78.3% |
2008-12-31 | $21.11 M | -34.7% |
2007-12-31 | $32.33 M | 46.4% |
2006-12-31 | $22.08 M | -51.44% |
2005-12-31 | $45.48 M | -9.19% |
2004-12-31 | $50.08 M | -20.31% |
2003-12-31 | $62.85 M | 54.11% |
2002-12-31 | $40.78 M | 21.86% |
2001-12-31 | $33.46 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Regeneron Pharmaceuticals REGN | $10.84 B | 2,994.19% | ๐บ๐ธ USA |
Pieris Pharmaceuticals PIRS | $44.81 M | -87.22% | ๐บ๐ธ USA |
Aeterna Zentaris AEZS | $34.01 M | -90.29% | ๐บ๐ธ USA |